Search
Feed aggregator
Breaking the Cycle of Inflammation in Parkinson’s Disease
Breaking the Cycle of Inflammation in Parkinson’s Disease 7/15/2024
5 Neuro Data Readouts to Watch in the Second Half of 2024
5 Neuro Data Readouts to Watch in the Second Half of 2024 7/15/2024
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological 7/15/2024
Opinion: Congress Must Reauthorize FDA Program for Pediatric Rare Diseases
Opinion: Congress Must Reauthorize FDA Program for Pediatric Rare Diseases 7/15/2024
Boehringer, Zealand Heat Up MASH Race With Strong Phase II Data
Boehringer, Zealand Heat Up MASH Race With Strong Phase II Data 6/7/2024
FDA Raises Concerns About Lilly’s Donanemab Alzheimer’s Candidate Ahead of Adcomm
FDA Raises Concerns About Lilly’s Donanemab Alzheimer’s Candidate Ahead of Adcomm 6/7/2024
FDA Approves Geron’s First-in-Class Telomerase Inhibitor for Blood Disorder
FDA Approves Geron’s First-in-Class Telomerase Inhibitor for Blood Disorder 6/7/2024
Biomea’s Stock Nosedives More Than 60% as FDA Puts Clinical Hold on Diabetes Candidate
Biomea’s Stock Nosedives More Than 60% as FDA Puts Clinical Hold on Diabetes Candidate 6/7/2024
MASH Clash Between Lilly and Boehringer-Zealand Takes Center Stage at EASL24
MASH Clash Between Lilly and Boehringer-Zealand Takes Center Stage at EASL24 6/7/2024
World Pharma News
- Researchers develop potent CDK9 inhibitor to overcome drug resistance in hematological malignancies
- Research opens up new avenue for tuberculosis drug discovery
- Aggressive skin cancer driven by mitochondrial processes - existing drugs offer promising treatment path
- Study highlights major hurdles for multinational clinical trials in Europe
- New model to find treatments for an aggressive blood cancer